S&P Futures
5,883.00 -13.25 (-0.22%) Dow Futures
43,100.00 -77.00 (-0.18%) Nasdaq Futures
20,452.75 -66.75 (-0.33%) Russell 2000 Futures
2,247.50 -8.00 (-0.35%) Crude Oil
70.50 -0.06 (-0.09%) Gold
2,748.90 +10.00 (+0.37%)
Ayurcann Holdings Corp. (AYUR.CN)
| Previous Close | 0.0450 |
| Open | 0.0000 |
| Bid | 0.0000 x N/A |
| Ask | 0.0000 x N/A |
| Day's Range | 0.0000 - 0.0000 |
| 52 Week Range | |
| Volume | |
| Avg. Volume | 14,010 |
| Market Cap | 9.735M |
| Beta (5Y Monthly) | 1.76 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0300 |
| Earnings Date | Oct 28, 2024 - Nov 01, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
GlobeNewswireAyurcann Holdings Corp is entering into a business combination with Arogo Capital Acquisition Corp. and its subsidiaries at a combined enterprise value estimated to be U.S. $210 million.
Ayurcann is an award-winning Canadian cannabis extraction company that specializes in the processing and manufacturing of cannabis 2.0 and 3.0 products: Ayurcann is the #1 producer of vapes in Ontario1, and Top 5 pre-roll manufacturer by volume in Ontario as of March 30, 20242. The revenue in the Canadian cannabis market is projected to reach US$5.63bn in 2024 and is expected to show an annual growth rate in the years 2024-2029 of 3.17%, resulting in a market volume of US$6.58bn by 20293.Upon co
- GlobeNewswire
AYURCANN REPORTS RECORD SALES IN Q3 2024 OF $11,655,360 FEATURING A 97% INCREASE IN GROSS REVENUE
Toronto, Ontario, May 27, 2024 (GLOBE NEWSWIRE) -- Ayurcann Holdings Corp. (CSE: AYUR, OTCQB: AYURF, FSE: 3ZQ0) (“Ayurcann” or the “Company”), a leading Canadian cannabis extraction company specializing in the processing and manufacturing of various cannabis 2.0 and 3.0 products in the recreational market, is pleased to announce its financial and operational results for the three and nine months ended March 31, 2024, the highlights of which are included in this news release. All figures are repo
